Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Phase 1b Registrational Clinical Study of SER-252 Underway in Advanced Parkinson's Disease; TFL data from the SAD study arm targeted for first half of 2027 -